These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

881 related articles for article (PubMed ID: 27624161)

  • 1. Untargeted Metabolomics Strategies-Challenges and Emerging Directions.
    Schrimpe-Rutledge AC; Codreanu SG; Sherrod SD; McLean JA
    J Am Soc Mass Spectrom; 2016 Dec; 27(12):1897-1905. PubMed ID: 27624161
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Data acquisition workflows in liquid chromatography coupled to high resolution mass spectrometry-based metabolomics: Where do we stand?
    Fenaille F; Barbier Saint-Hilaire P; Rousseau K; Junot C
    J Chromatogr A; 2017 Dec; 1526():1-12. PubMed ID: 29074071
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Challenges and emergent solutions for LC-MS/MS based untargeted metabolomics in diseases.
    Cui L; Lu H; Lee YH
    Mass Spectrom Rev; 2018 Nov; 37(6):772-792. PubMed ID: 29486047
    [TBL] [Abstract][Full Text] [Related]  

  • 4. After the feature presentation: technologies bridging untargeted metabolomics and biology.
    Cho K; Mahieu NG; Johnson SL; Patti GJ
    Curr Opin Biotechnol; 2014 Aug; 28():143-8. PubMed ID: 24816495
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Mass spectrometry based untargeted metabolomics for plant systems biology.
    Alvarez S; Naldrett MJ
    Emerg Top Life Sci; 2021 May; 5(2):189-201. PubMed ID: 33704399
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Untargeted detection of the carbonyl metabolome by chemical derivatization and liquid chromatography-tandem mass spectrometry in precursor ion scan mode: Elucidation of COVID-19 severity biomarkers.
    Gomez-Gomez A; Rodríguez-Morató J; Haro N; Marín-Corral J; Masclans JR; Pozo OJ
    Anal Chim Acta; 2022 Mar; 1196():339405. PubMed ID: 35151400
    [TBL] [Abstract][Full Text] [Related]  

  • 7. An improved detection and identification strategy for untargeted metabolomics based on UPLC-MS.
    Hou Y; He D; Ye L; Wang G; Zheng Q; Hao H
    J Pharm Biomed Anal; 2020 Nov; 191():113531. PubMed ID: 32889345
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Development of simultaneous targeted metabolite quantification and untargeted metabolomics strategy using dual-column liquid chromatography coupled with tandem mass spectrometry.
    Gao Y; Chen Y; Yue X; He J; Zhang R; Xu J; Zhou Z; Wang Z; Zhang R; Abliz Z
    Anal Chim Acta; 2018 Dec; 1037():369-379. PubMed ID: 30292313
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Promises and pitfalls of untargeted metabolomics.
    Gertsman I; Barshop BA
    J Inherit Metab Dis; 2018 May; 41(3):355-366. PubMed ID: 29536203
    [TBL] [Abstract][Full Text] [Related]  

  • 10. LC-MS untargeted metabolomics assesses the delayed response of glufosinate treatment of transgenic glufosinate resistant (GR) buffalo grasses (Stenotaphrum secundatum L.).
    Boonchaisri S; Rochfort S; Stevenson T; Dias DA
    Metabolomics; 2021 Feb; 17(3):28. PubMed ID: 33609206
    [TBL] [Abstract][Full Text] [Related]  

  • 11. MARS: A Multipurpose Software for Untargeted LC-MS-Based Metabolomics and Exposomics.
    Goracci L; Tiberi P; Di Bona S; Bonciarelli S; Passeri GI; Piroddi M; Moretti S; Volpi C; Zamora I; Cruciani G
    Anal Chem; 2024 Jan; 96(4):1468-1477. PubMed ID: 38236168
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Comparison of peak-picking workflows for untargeted liquid chromatography/high-resolution mass spectrometry metabolomics data analysis.
    Rafiei A; Sleno L
    Rapid Commun Mass Spectrom; 2015 Jan; 29(1):119-27. PubMed ID: 25462372
    [TBL] [Abstract][Full Text] [Related]  

  • 13. MS
    Folberth J; Begemann K; Jöhren O; Schwaninger M; Othman A
    J Chromatogr B Analyt Technol Biomed Life Sci; 2020 May; 1145():122105. PubMed ID: 32305706
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Enhanced MS/MS coverage for metabolite identification in LC-MS-based untargeted metabolomics by target-directed data dependent acquisition with time-staggered precursor ion list.
    Wang Y; Feng R; Wang R; Yang F; Li P; Wan JB
    Anal Chim Acta; 2017 Nov; 992():67-75. PubMed ID: 29054151
    [TBL] [Abstract][Full Text] [Related]  

  • 15. The evolving landscape of untargeted metabolomics.
    Di Minno A; Gelzo M; Stornaiuolo M; Ruoppolo M; Castaldo G
    Nutr Metab Cardiovasc Dis; 2021 Jun; 31(6):1645-1652. PubMed ID: 33895079
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Challenges, progress and promises of metabolite annotation for LC-MS-based metabolomics.
    Chaleckis R; Meister I; Zhang P; Wheelock CE
    Curr Opin Biotechnol; 2019 Feb; 55():44-50. PubMed ID: 30138778
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Quantitative Metabolomics of Saccharomyces Cerevisiae Using Liquid Chromatography Coupled with Tandem Mass Spectrometry.
    Mohammad K; Jiang H; Titorenko VI
    J Vis Exp; 2021 Jan; (167):. PubMed ID: 33491678
    [TBL] [Abstract][Full Text] [Related]  

  • 18. An untargeted metabolomics-driven approach based on LC-TOF/MS and LC-MS/MS for the screening of xenobiotics and metabolites of Zhi-Zi-Da-Huang decoction in rat plasma.
    Wu H; Li X; Yan X; An L; Luo K; Shao M; Jiang Y; Xie R; Feng F
    J Pharm Biomed Anal; 2015 Nov; 115():315-22. PubMed ID: 26275719
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Investigation of altered urinary metabolomic profiles of invasive ductal carcinoma of breast using targeted and untargeted approaches.
    More TH; Taware R; Taunk K; Chanukuppa V; Naik V; Mane A; Rapole S
    Metabolomics; 2018 Aug; 14(8):107. PubMed ID: 30830381
    [TBL] [Abstract][Full Text] [Related]  

  • 20.
    ; ; . PubMed ID:
    [No Abstract]   [Full Text] [Related]  

    [Next]    [New Search]
    of 45.